CFTR and cystic fibrosis: The CF community is therefore also exploring how functional studies of CFTR modulators in patient-derived cells can be used as a ‘theranostic’ tool, to predict the likelihood of treatment benefit for individuals based on treatment response in their cultured cells [19,20,21].